证券日报网讯爱威科技11月25日在互动平台回答投资者提问时表示，公司2025年前三季度研发投入金额 同比增长7.28%，研发投入营收占比同比略降是由于营业收入同比增长所致。公司一直重视研发创新工 作，上市以来研发投入营收占比一直在10%以上，未来也将继续保持高强度研发投入，促进企业核心竞 争力的持续提升。 ...

证券之星消息，远东传动(002406)11月24日在投资者关系平台上答复投资者关心的问题。 投资者提问：贵公司如何提升公司业绩或者市值呢 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 远东传动回复：您好！公司一直非常重视投资者关系管理和市值管理工作。公司持续聚焦发展主业，不 断加大智能制造、研发创新和新能源汽车市场拓展，延长产业链，提高公司核心竞争力，保持公司长 期、稳定、高质量可持续发展，自上市以来，保持每年现金分红，累计实现分红总额12.85亿元，股利 支付率达90%以上，同时及时做好投资者关系管理和信息披露相关工作，引导股东长期投资，回报投资 者的关心和支持。股票市场投资收益与风险并存，股票价格的波动不仅受公司盈利水平和发展前景的影 响，而且受国家宏观经济政策调整、金融政策的调控、股票市场的投机行为、投资者的心理预期等诸多 因素的影响，请广大投资者理性投资，注意风险。谢谢！ ...

Core Viewpoint - Hunan's industrial enterprises are focusing on R&D innovation during the "14th Five-Year Plan" period, enhancing product service quality and optimizing production processes to achieve significant advancements in the industrial chain [7][10]. Group 1: Industrial Transformation - Hunan's industrial sector is undergoing significant transformation through technological upgrades, intelligent modifications, and green reforms, revitalizing traditional industries [8]. - The automation and intelligence in production processes have reduced the need for manual labor by over 50% in companies like Xiangtan Steel Group, enhancing product performance and market recognition [8][9]. - Xiangtan Steel has successfully developed over 100 high-end steel varieties, achieving full specification coverage and gaining recognition from major clients [9]. Group 2: Economic Impact - In 2023, Xiangtan City initiated 448 "three reforms and one expansion" projects, with completed projects generating over 37 billion yuan in new annual output value and over 1.9 billion yuan in new tax revenue [10]. - Completed projects have improved overall production efficiency by over 20% and significantly reduced pollution emissions [10]. Group 3: R&D and Innovation - Hunan's industrial and information technology department reports an average annual growth of 7% in industrial added value from 2021 to 2024, surpassing the national average [11]. - The province is fostering a high-tech manufacturing environment, with a focus on smart manufacturing and continuous R&D investment, which is crucial for future growth [14][17]. - Companies like Hunan Saidelete Satellite Technology are prioritizing R&D, with over 75% of their workforce dedicated to research, showcasing the importance of innovation in the industrial landscape [15]. Group 4: Collaboration and Future Directions - The collaboration among industry players is essential for overcoming challenges and achieving technological advancements, as seen in the efforts of companies like CRRC Zhuzhou Electric Locomotive [12][13]. - Hunan aims to enhance its industrial economy by focusing on smart, green, and integrated development, thereby creating a new growth trajectory for its industrial sector [17].

进入四季度，气温趋寒，大龙开发区北部工业园区却热潮涌动。从劳动密集型企业车间到高新技术产业工地，生产线高速运转、运输车辆往来穿梭，产业 工人各司其职、干劲拉满，全力赶订单、扩产能，以实干姿态冲刺全年发展目标。 罗彬在指导工人 大龙开发区产业集群航拍 走进开发区贵州阳光箱包生产车间，百余台缝纫设备火力全开，工人专注推进裁剪、缝纫、锁边、质检等工序，布料经指尖加工逐步成型，设计新颖、做 工精细的箱包接连下线，即将发往国内外市场。 "当前订单储备充足，正全力赶制34500个箱包，涵盖出口俄罗斯及国内市场订单。"阳光箱包生产车间负责人罗彬介绍，预计今年企业可生产箱包35万 个，实现产值1500万元，较去年同比增长36%。 阳光箱包生产车间 贵州阳光箱包成立于2016年11月，是集研发、生产、销售于一体的综合性箱包企业，主营书包、旅行包、休闲包、背包等品类，拥有"澳普森""佐丹"等高 端品牌供应国内实体市场，产品远销欧洲、澳洲、东南亚等60余个国家和地区。 今年以来，企业生产线由4条扩充至5条，生产规模与效率同步提升。"依托开发区区位优势与政策扶持，我们稳步扩产，今年秋季广交会上更是收获颇 丰，累计接到300万美元订单 ...

更重要的是，医疗器械从低端到高端的技术突破是一个逐步积累的过程，不存在弯道超车的现象，因此 更加需要公司在研发上踏踏实实地做好每一步。公司未来将持续加大研发创新，通过开发更高性能的试 剂、成像更清晰的影像设备来尽早发现疾病，通过更精准易用的微创或介入器械让疾病在早期就能得到 治愈，通过数智化解决方案提高医疗水平均质化的同时，帮助医院提质增效、控费降本等等，最终将优 质的生命关怀惠及到更多人。 近期有投资者在互动易平台问到，"迈瑞医疗是否有进一步加大研发投入的计划？" 迈瑞医疗认为，医疗器械的创新研发和其他行业很不一样，即使创造出了新的技术路径，首先技术需要 成熟、原理清晰，其次在全球顶级专家认可、临床验证、产品注册等环节中仍需要经历非常漫长且复杂 的过程。 迈瑞医疗回应称，"多年来，迈瑞医疗坚持研发高投入，即使在营收规模快速增长的情况下，依然坚持 将每年营收的约10%投入研发，研发投入比例和规模均在医疗器械企业中处于领先地位。截至2025年三 季度末，公司自2018年登陆A股以来累计研发投入已达到215.56亿元，为公司的未来发展筑牢核心研发 支撑。" 迈瑞医疗在互动易中表示，"公司的除颤仪从研发到上市共经历 ...

华为一开始就是为理想而奋斗，不是为金钱而奋斗，这是华为有长期奋斗动力的根源之一。 下面是我从任正非那里感悟到的一些心得，希望对你有启发。 1、任何团队都必须有合理的淘汰机制，没有新陈代谢是不行的，正常的流动是好的，老板不要觉得员工跟自己时间越长越好。 有时候我听一些老板很自豪"某个人跟了我七八年"，他的意思是自己有领导力，公司发展好，员工在这里很满意。 但反过来看也许就是惰怠和官僚主义，流水不腐户枢不蠹，公司内部一定要流动起来才有活力和战斗力。 否则就容易成为一潭死水，公司规模大了就是内部帮派林立，处处都是土围子，各自为政，在大船里开小船。 末位淘汰也可以是激励，是对团队、组织的激活。 2、努力奋斗必须要有正确的方向，没有大致正确的方向就不会达成目标。 很多人都搞不懂什么是方向，问他们创业是为啥，他们就说是为了赚钱，但钱是一个值得奋斗的目标吗？ 还是要有理想主义。钱本身是虚无的，没有价值，因为钱不会不属于任何人，钱是锚定在价值之上的，金钱生不带来死不带去，我们要找到"假"背后 的"真"才行。 老方说任正非真的是理想主义者，这点跟他同时期的企业家对比看就特别明显。至于目标和方向的关系，其实你有了正确的目标后，你 ...

Core Viewpoint - Company maintains a strong commitment to R&D investment, allocating approximately 10% of annual revenue to R&D, which is among the highest in the medical device industry [1][2] Group 1: R&D Investment - Cumulative R&D investment reached 21.556 billion yuan since the company went public in 2018, reinforcing its core R&D capabilities for future growth [1] - The company emphasizes the importance of R&D innovation as a driving force, continuously increasing investment to develop market-relevant products [1] Group 2: Industry Challenges - The development of medical devices, such as defibrillators, involves a lengthy process, taking up to ten years from R&D to market launch, with five years dedicated to establishing certification standards [2] - The company acknowledges that technological breakthroughs in medical devices require a gradual accumulation of knowledge and cannot be achieved through shortcuts [2] Group 3: Future Directions - The company plans to enhance R&D innovation by developing higher-performance reagents and clearer imaging devices for early disease detection, as well as more precise and user-friendly minimally invasive instruments [2] - The goal is to improve healthcare quality and efficiency while reducing costs, ultimately extending quality healthcare to a broader population [2]

证券日报网讯康缘药业11月18日在互动平台回答投资者提问时表示，公司始终坚定研发创新，各创新药 研发管线稳步推进，希望未来能提供更多满足市场临床需求、具备差异化竞争优势的创新药产品组合， 增强公司市场竞争力。 （文章来源：证券日报） ...

Group 1: Company Overview - The company operates in three main sectors: special products, automotive parts, and strategic emerging industries [2][3] - Special products include lightweight weaponry, with exports to dozens of countries, focusing on modernization through mechanization, informatization, and intelligence [2] - The automotive parts sector includes components like connecting rods and braking systems, adapting to trends in electrification and lightweighting, with a leading market share in connecting rods [2] Group 2: Market Management and Investor Relations - The company emphasizes the importance of market value management, focusing on operational management, strategic planning, and enhancing communication with market participants [3] - There is currently no equity incentive plan, but any future plans will comply with legal disclosure requirements [3] Group 3: Research and Development - In the first half of 2025, the company invested ¥118,603,321.52 in R&D, representing a year-on-year increase of 16.44% [3] Group 4: Financial Management - As of Q3 2025, accounts receivable amounted to ¥1,670,123,877.30, an increase of 24.49% from the beginning of the year, with measures in place for monitoring and collection [3] - The company has made adequate provisions for potential impairment losses in accordance with accounting standards [3] Group 5: Shareholder Information - As of November 10, 2025, the number of shareholders is 90,600 [4]

Core Viewpoint - The company plans to issue A-shares to specific investors to raise a total of no more than 1.897 billion yuan for various projects including capacity expansion and technological upgrades [1] Group 1: Fundraising Details - The total amount to be raised is capped at 1.897 billion yuan [1] - The funds will be allocated to projects such as the expansion of high-performance aluminum profiles and components for automotive lightweighting in East and South China, the establishment of a research and innovation center, and the intelligent technology transformation of the South China production base [1] - The issuance will target no more than 35 specific investors, including qualified securities investment fund management companies and securities firms as per the regulations of the China Securities Regulatory Commission [1] Group 2: Issuance Conditions - The issuance price will not be lower than 80% of the average stock price over the 20 trading days prior to the pricing benchmark [1] - There will be a lock-up period of six months starting from the end of the issuance [1]